Oftaquix (Levofloxacin Hemihydrate)

Oftaquix, a fluoroquinolone antibiotic, is indicated for several bacterial infections affecting different organ systems.

• Community‑acquired bacterial pneumonia: eradicates susceptible respiratory pathogens and improves clinical outcomes.
• Acute bacterial sinusitis: reduces sinus inflammation and bacterial load.
• Uncomplicated urinary tract infection: clears uropathogens and resolves symptoms.
• Skin and soft‑tissue infections: treats susceptible Gram‑positive and Gram‑negative bacteria.
• Acute exacerbation of chronic bronchitis: controls bacterial proliferation and aids recovery.

• Levofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By stabilizing the DNA‑enzyme complex, it prevents the resealing of DNA strands, leading to bacterial cell death and a bactericidal effect against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Levofloxacin may cause a range of adverse reactions, from mild to severe. Awareness of these effects helps clinicians monitor patients appropriately.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: often self‑limiting.
• Headache: transient and usually resolves.
• Dizziness: may affect balance.
• Abdominal pain: discomfort in the stomach area.
• Rash: mild skin irritation.

Serious or Rare Side Effects

• Tendon rupture: especially Achilles tendon, may occur without warning.
• QT interval prolongation: risk of cardiac arrhythmias.
• Severe allergic reactions: anaphylaxis or angioedema.
• Clostridioides difficile infection: colitis with watery diarrhea.
• Peripheral neuropathy: sensory disturbances.
• Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Levofloxacin requires careful patient assessment and monitoring to minimize risks.

• Renal impairment: dose adjustment may be necessary based on kidney function.
• History of tendon disorders: avoid use or monitor closely for tendon pain.
• QT prolongation risk: obtain baseline ECG and monitor cardiac rhythm.
• Pregnancy and lactation: prescribe only if benefits outweigh potential fetal or infant risks.
• Concomitant medications: review for interactions that may increase toxicity.
• Store at room temperature: keep in original container, protect from moisture and light.

Levofloxacin can alter the activity of several co‑administered drugs, necessitating vigilance.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption.
• Warfarin: may increase anticoagulant effect and bleeding risk.
• Theophylline: elevated serum theophylline levels can cause toxicity.
• Cyclosporine: increased risk of nephrotoxicity.
• NSAIDs: heightened risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely)

• Ciprofloxacin: additive QT‑prolongation potential.
• Rifampin: may lower levofloxacin plasma concentrations.
• Diabetes medications (insulin, sulfonylureas): possible alterations in glucose control.